Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Using a robotic system to improve ACL surgery precision

Official title: Assessing the Efficacy of a Preoperative Navigation System in Anterior Cruciate Ligament Reconstruction

Run by Beijing Tsinghua Chang Gung Hospital · NCT06858930 · Data updated 2026-11-12

This study tests if using a robotic system during ACL surgery can make the surgery more accurate and improve recovery for patients.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment76 (estimated)
SponsorBeijing Tsinghua Chang Gung Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedJanuary 24, 2025
Main results expectedJanuary 24, 2025
Study endsJanuary 24, 2029
Registry record updatedMarch 5, 2025
Trial IDNCT06858930 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals aged 18 to 80 with a diagnosed ACL tear who are willing to participate in follow-up observations.

Probably not a fit

Patients with severe obesity, systemic diseases that prevent surgery, or active infections may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates a robotic system designed to enhance the accuracy of bone tunnel placement during anterior cruciate ligament (ACL) reconstruction surgery. The study employs a randomized controlled trial methodology to compare outcomes between surgeries performed with robotic assistance and those done manually. It aims to demonstrate the effectiveness of this innovative technology in improving surgical results and minimizing complications. Conducted across multiple centers in China, the trial is led by a prominent professor from Tsinghua University and has received necessary clinical registration.

Why it matters

Potential benefit: If successful, this approach could lead to improved surgical outcomes and reduced complications for patients undergoing ACL reconstruction.

How similar studies have gone: Other studies have shown promising results with robotic-assisted surgeries, indicating potential success for this novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Preoperatively, the participant or guardian is willing and able to sign the informed consent form;
2. Patients aged 18 to 80 years (inclusive of 18 and 80 years), regardless of gender;
3. Patients who meet the diagnostic criteria for anterior cruciate ligament (ACL) tear and have no contraindications for implantation;
4. Patients with mature skeletons;
5. Good compliance and willingness and ability to participate in follow-up observations as required.

Exclusion Criteria:

* (1) Participants who have previously participated in other clinical studies of drugs, biological agents, or medical devices but did not meet the primary study endpoint within the specified timeframe; (2) Patients with a known allergy to one or more implanted materials; (3) Patients who are physically frail or unable to tolerate surgery due to other systemic diseases; (4) Presence of active infectious lesions in the knee joint or other parts of the body; (5) Obesity with a BMI \> 35; (6) Patients with severe diabetes (acute complications of diabetes, preoperative random blood glucose ≥ 16.7 mmol/L with or without altered consciousness, such as diabetic ketoacidosis, suspected diabetic ketoacidosis, hyperglycemic hyperosmolar state, or lactic acidosis; chronic complications of diabetes leading to severe target organ damage requiring urgent treatment, such as acute cardiovascular and cerebrovascular diseases, renal insufficiency, severe vision loss due to retinal disease, intermittent claudication and ischemic symptoms due to peripheral vascular disease, diabetic foot); (7) Women who are pregnant or breastfeeding; (8) Drug users and substance abusers; (9) Patients who are mentally incapacitated or unable to understand the requirements for participating in the study, making cooperation difficult; (10) Those expected to have poor compliance, unwilling or unable to follow postoperative therapy and/or rehabilitation program instructions; (11) Other comorbid conditions that limit participation in the study, hinder compliance with follow-up, or affect the scientific integrity of the study; (12) Other conditions judged by the investigator to be unsuitable for inclusion.

Where it's running

  • Beijing Tsinghua Chang Gung Hospital.
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.